Research compounds, also often referred to as "research chem" or "novel compounds," represent a somewhat new domain of scientific investigation. They are typically synthesized by labs, frequently outside established pharmaceutical channels, and aren't yet fully investigated for human consumption or

Innovative retatrutide, a combined-action drug targeting equally GLP-1 and GIP receptors, is creating considerable buzz within the weight loss community. Early clinical studies have shown substantial losses in physical size and advancements in physiological markers for individuals with obesity . Ex